Benzinga
JULY 5, 2022
Investors in $110 million Series D financing include Medtronic and Terumo as well as lead investor RTW Investments and founding investor Perceptive Advisors. The Series D financing was not contingent on the consummation of the Business Combination.
Benzinga
DECEMBER 21, 2022
Pro forma enterprise value of the combined company is expected to be approximately $475 million, including $50M seller earnout. 10X III and Sparks have secured a $50 million committed equity financing facility. A $50 million standby equity financing facility has been secured from YA II PN, LTD.,
Benzinga
MARCH 27, 2024
million common shares as part of the Transaction, representing an equity value of approximately US$276 million on a fully diluted in-the-money basis, and an enterprise value of US$516 million. This financing will allow Argonaut to fund its immediate liquidity needs related to its loan facilities and operations.
Expert insights. Personalized for you.
40 
Let's personalize your content